Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma (Q38388465)

2 September 2017

title

Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma (English)

1 reference

2 September 2017

main subject

protein ubiquitination

1 reference

Xiao-Fei Zhang

1

1 reference

2 September 2017

Qiu-Zhong Pan

2

1 reference

2 September 2017

Ke Pan

3

1 reference

2 September 2017

De-Sheng Weng

4

1 reference

2 September 2017

Qi-Jing Wang

5

1 reference

2 September 2017

Jing-Jing Zhao

6

1 reference

2 September 2017

Jia He

7

1 reference

2 September 2017

Qing Liu

8

1 reference

2 September 2017

Dan-Dan Wang

9

1 reference

2 September 2017

Shan-Shan Jiang

10

1 reference

2 September 2017

Hai-Xia Zheng

11

1 reference

2 September 2017

Lin Lv

12

1 reference

2 September 2017

Chang-Long Chen

13

1 reference

2 September 2017

Hong-Xia Zhang

14

1 reference

2 September 2017

Jian-Chuan Xia

15

1 reference

2 September 2017

publication date

3 January 2015

1 reference

2 September 2017

published in

Molecular Carcinogenesis

1 reference

2 September 2017

volume

55

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

64-76

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

2 September 2017

cites work

1 reference

21 January 2018

Global cancer statistics

1 reference

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

U box proteins as a new family of ubiquitin-protein ligases

21 January 2018

1 reference

A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.

21 January 2018

1 reference

21 January 2018

1 reference

A proteolytic pathway that recognizes ubiquitin as a degradation signal

21 January 2018

1 reference

21 January 2018

Surfing the p53 network

1 reference

Awakening guardian angels: drugging the p53 pathway

21 January 2018

1 reference

UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53.

21 January 2018

1 reference

UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation

21 January 2018

1 reference

CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.

21 January 2018

1 reference

Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis.

21 January 2018

1 reference

UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination

21 January 2018

1 reference

U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha

21 January 2018

1 reference

Cell death independent of caspases: a review.

21 January 2018

1 reference

Regulation of p53 downstream genes.

21 January 2018

1 reference

The ubiquitin pathway: an emerging drug target in cancer therapy

21 January 2018

1 reference

Ubiquitin-dependent protein degradation

21 January 2018

1 reference

Selective protein degradation: a journey's end within the proteasome

21 January 2018

1 reference

Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade

21 January 2018

1 reference

UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors

21 January 2018

1 reference

A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation

21 January 2018

1 reference

Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.

21 January 2018

1 reference

Frameshift mutations of ubiquitination-related genes HERC2, HERC3, TRIP12, UBE2Q1 and UBE4B in gastric and colorectal carcinomas with microsatellite instability.

21 January 2018

1 reference

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.22259

1 reference

2 September 2017

1 reference